Rui Qiao
12 papers in the catalog · Canada
Rui Qiao: 12 papers in the catalog · Canada · Bioinformatics Solutions Inc., University of Waterloo · Works on DIAVariant, DeepNovo Peptidome, DeepNovo V2
Affiliations
- Bioinformatics Solutions Inc.
- University of Waterloo · Department of Statistics and Actuarial Science
Elsewhere
Papers
- De Novo sequencing-assisted homology search for DIA data analysis enables low abundance peptide variants discovery (2025, bioRxiv)
- NovoBoard: A Comprehensive Framework for Evaluating the False Discovery Rate and Accuracy of De Novo Peptide Sequencing (2024, Molecular & Cellular Proteomics)
- NovoBoard: a comprehensive framework for evaluating the false discovery rate and accuracy of de novo peptide sequencing (2024, bioRxiv)
- A complete mass spectrometry-based immunopeptidomics pipeline for neoantigen identification and validation (2023, Research Square)
- Discovering and Validating Neoantigens by Mass Spectrometry-based Immunopeptidomics and Deep Learning (2022, bioRxiv)
- A streamlined platform for analyzing tera-scale DDA and DIA mass spectrometry data enables highly sensitive immunopeptidomics (2022, Nature Communications)
- Computationally instrument-resolution-independent de novo peptide sequencing for high-resolution devices (2021, Nature Machine Intelligence)
- Personalized deep learning of individual immunopeptidomes to identify neoantigens for cancer vaccines (2020, Nature Machine Intelligence)
- Peptide Sequencing with Deep Learning (2020)
- Personalized deep learning of individual immunopeptidomes to identify neoantigens for cancer vaccines (2019, bioRxiv)
- DeepNovoV2: Better de novo peptide sequencing with deep learning (2019, arXiv)
- Deep learning enables de novo peptide sequencing from data-independent-acquisition mass spectrometry (2018, Nature Methods)
Thesis supervisor
Methods and tools
DIAVariant, DeepNovo Peptidome, DeepNovo V2, DeepNovo-DIA, DeepNovoAA, NovoBoard, PEAKS, PointNovo
Patents (3)
- US11694769B2 Systems and methods for de novo peptide sequencing from data-independent acquisition using deep learning ↗ (Bioinformatics Solutions Inc., priority 2017-07-17, active)
- US20200243164A1 Systems and methods for patient-specific identification of neoantigens by de novo peptide sequencing for personalized immunotherapy ↗ (Bioinformatics Solutions Inc., priority 2019-01-30, abandoned)
- US11644470B2 Systems and methods for de novo peptide sequencing using deep learning and spectrum pairs ↗ (Bioinformatics Solutions Inc., priority 2019-04-15, active)
Patent families naming this author as an inventor. The link is made only where the same person is evident: they wrote a paper describing the patented method, or worked at the assignee.